Holen Sie sich die Stockscreener-App
4.95
1.79%
-0.09
Handel nachbörslich:
4.90
-0.05
-1.01%
Schlusskurs vom Vortag:
$5.04
Offen:
$5.04
24-Stunden-Volumen:
2.76M
Relative Volume:
0.72
Marktkapitalisierung:
$1.22B
Einnahmen:
$427.68M
Nettoeinkommen (Verlust:
$-58.06M
KGV:
-20.78
EPS:
-0.2382
Netto-Cashflow:
$-37.50M
1W Leistung:
-1.59%
1M Leistung:
-2.94%
6M Leistung:
-35.63%
1J Leistung:
+16.75%
1-Tages-Spanne:
$4.92
$5.05
1-Wochen-Bereich:
$4.905
$5.21
52-Wochen-Spanne:
$4.075
$8.40
Ardelyx Inc Stock (ARDX) Company Profile
Firmenname
Ardelyx Inc
Sektor
Branche
Telefon
510-745-7047
Adresse
34175 ARDENWOOD BLVD., FREMONT, CA
Compare ARDX vs VRTX, REGN, ARGX, RVMD, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
4.95 | 1.25B | 427.68M | -58.06M | -37.50M | -0.2382 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-09-03 | Fortgesetzt | Raymond James | Strong Buy |
| 2025-06-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-05-02 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2025-03-07 | Fortgesetzt | Ladenburg Thalmann | Buy |
| 2025-03-04 | Eingeleitet | BTIG Research | Buy |
| 2024-11-11 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-18 | Eingeleitet | Raymond James | Strong Buy |
| 2023-09-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-08-25 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | Hochstufung | Wedbush | Neutral → Outperform |
| 2022-11-17 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | Herabstufung | Jefferies | Buy → Hold |
| 2021-07-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | Herabstufung | Wedbush | Outperform → Neutral |
| 2021-03-23 | Eingeleitet | Wedbush | Outperform |
| 2021-01-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-10-20 | Fortgesetzt | Citigroup | Buy |
| 2020-02-18 | Fortgesetzt | Jefferies | Buy |
| 2020-02-12 | Eingeleitet | Citigroup | Buy |
| 2020-02-10 | Eingeleitet | Cowen | Outperform |
| 2019-04-08 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-08-24 | Eingeleitet | Jefferies | Buy |
| 2018-03-19 | Fortgesetzt | Leerink Partners | Outperform |
| 2017-11-29 | Bestätigt | Citigroup | Buy |
| 2017-11-22 | Bestätigt | Ladenburg Thalmann | Buy |
| 2017-10-17 | Fortgesetzt | Leerink Partners | Outperform |
| 2016-03-31 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2016-03-09 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2016-03-03 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Ardelyx Inc Aktie (ARDX) Neueste Nachrichten
Ardelyx Inc (ARDX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ARDX|Ardelyx Inc|Price:5.030|Chg%:-0.100 - TradingKey
Ardelyx Inc (ARDX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Ardelyx Inc (ARDX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Ardelyx (ARDX) Faces A Valuation Test, Is The Discount Too Wide? - simplywall.st
TradingKey - TradingKey
Ardelyx Inc (ARDX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ARDX Stock Jumps Over 5% Overnight As Director Loads Up In Vote Of Confidence For Flagship Constipation Drug - Stocktwits
Ardelyx Inc (ARDX) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
Ardelyx, Inc. Revenue Breakdown – NASDAQ:ARDX - TradingView
Ardelyx, Inc. (ARDX) Stock Price, News, Quote & History - Yahoo! Finance Canada
ARDX Edges Up After Hours On IBSRELA Momentum And Profitability ‘Right Around The Corner’ - Stocktwits
Ardelyx Inc (ARDX) Institutional Confidence - TradingKey
Ardelyx, Inc. (ARDX) stock price, news, quote and history - Yahoo Finance Singapore
Ardelyx Schedules Second Quarter 2026 Financial Results Webcast for August 6, 2026 - scanx.trade
ARDX: Ardelyx Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Ardelyx to Report Second Quarter 2026 Financial Results on August 6, 2026 - The Manila Times
Ardelyx schedules webcast, call to discuss Q2 results and business update - Bitget
ARDX Q1 2026 Earnings: EPS Misses Estimates as Revenue Details Remain UnavailableBanking Earnings Report - po-news-eg.net
ETFs Investing in Ardelyx, Inc. Stocks - TradingView
How Investors Are Reacting To Ardelyx (ARDX) Hedge Fund Buying Despite Medicare Setback - simplywall.st
Claude AI Says Market is Ignoring Ardelyx (ARDX) Growth Catalysts - Yahoo Finance
ARDX Stock Is Down Pre-Market After Q4 Earnings Miss, So Why Did This Firm Just Hike Price Target By 80%? - Stocktwits
High Growth Tech Stocks In The US Market - simplywall.st
Ardelyx (ARDX) Pulls Back As Growth Narrative Raises The Question Of Value - simplywall.st
Ardelyx CEO Michael Raab disposes of 41,668 common shares worth $210,884.22 - Bitget
Form 4 Ardelyx Inc For: 17 July By Investing.com - Investing.com Nigeria
Ardelyx CEO Michael Raab sells $210,923 in stock By Investing.com - Investing.com South Africa
Ardelyx CEO Michael Raab sells $210,923 in stock - Investing.com
Form 4 Ardelyx Inc For: 17 July - Investing.com India
Ardelyx CEO sells shares, exercises options | ARDX Insider Trading - Stock Titan
Lobbying Update: $500,000 of ARDELYX INC. lobbying was just disclosed - Quiver Quantitative
Trading the Move, Not the Narrative: (ARDX) Edition - Stock Traders Daily
Ardelyx (ARDX) Receives a Buy from Wedbush - The Globe and Mail
Wedbush Maintains Ardelyx(ARDX.US) With Buy Rating, Raises Target Price to $19 - Moomoo
Lobbying Update: $20,000 of ARDELYX INC lobbying was just disclosed - Quiver Quantitative
Ardelyx Secures New $50 Million Term F Loan - The Globe and Mail
Ardelyx (NASDAQ: ARDX) draws $50M Term F loan maturing in 2030 - Stock Titan
Ardelyx: The Market Is Right To Discount This Revenue Growth - Seeking Alpha
Price to book forward of Ardelyx, Inc. – NASDAQ:ARDX - TradingView
Enterprise value to revenue forward of Ardelyx, Inc. – NASDAQ:ARDX - TradingView
Enterprise value to EBITDA forward of Ardelyx, Inc. – NASDAQ:ARDX - TradingView
Price to sales forward of Ardelyx, Inc. – NASDAQ:ARDX - TradingView
Price to earnings forward of Ardelyx, Inc. – TRADEGATE:41X - TradingView
Ardelyx, Inc.'s (NASDAQ:ARDX) Shift From Loss To Profit - 富途牛牛
Ardelyx (ARDX) Faces New Medicare Rules For Xphozah After Court Ruling - simplywall.st
Finanzdaten der Ardelyx Inc-Aktie (ARDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ardelyx Inc-Aktie (ARDX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| RAAB MICHAEL | President & CEO |
Jul 15 '26 |
Sale |
5.06 |
41,668 |
210,923 |
1,678,366 |
| Williams Laura A | Chief Patient Officer |
Jun 18 '26 |
Option Exercise |
0.99 |
31,000 |
30,690 |
460,093 |
| Williams Laura A | Chief Patient Officer |
Jun 18 '26 |
Sale |
5.99 |
81,898 |
490,487 |
378,195 |
2.44%
0.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):